• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharma Advanced Research Company Limited — Board Meeting, 10-11-2025: Outcome of Board Meeting

    10-11-2025 | 09:03 pm

    SPARC's board approved Q2 and H1 FY26 consolidated financial results, reporting a net loss of ₹75.85 Cr for Q2 and ₹127.72 Cr for H1. Revenue was ₹7.86 Cr (Q2) and ₹17.50 Cr (H1). The company also incorporated Genokine Biotech, a new wholly-owned subsidiary.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharma Advanced Research Company Limited